Search research articles
Contact Us
Filters
Showing results (21-30 of 342) with videos related to
Page
of 35
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 3, 2009
Safety profile of Tysabri: international risk management plan
P Iaffaldano, M D'Onghia, Maria Trojano
Biologics : Targets & Therapy
|
August 27, 2009
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
Damiano Paolicelli, Vita Direnzo, Maria Trojano
Neurology
|
April 25, 2018
Complexity of MS management in the current treatment era
Tanuja Chitnis, Gavin Giovannoni, Maria Trojano
Expert Review of Neurotherapeutics
|
November 19, 2011
Treating multiple sclerosis with natalizumab
Pietro Iaffaldano, Guglielmo Lucchese, Maria Trojano
Journal of Neurology
|
June 5, 2016
Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients
Pietro Iaffaldano, Rosa Gemma Viterbo, Maria Trojano
Neurology
|
October 16, 2013
Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient
Carla Tortorella, Vita Direnzo, Mariangela D'Onghia, et al.
CNS Drugs
|
January 4, 2020
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis
Damiano Paolicelli, Alessia Manni, Antonio Iaffaldano, et al.
CNS Drug Reviews
|
July 14, 2007
Glatiramer acetate in multiple sclerosis: a review
Maddalena Ruggieri, Carlo Avolio, Paolo Livrea, et al.
Clinical and Experimental Medicine
|
December 26, 2014
First evidence of in vivo pro-angiogenic activity of cerebrospinal fluid samples from multiple sclerosis patients
Domenico Ribatti, Pietro Iaffaldano, Christian Marinaccio, et al.
Acta Neuropathologica Communications
|
July 23, 2014
Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
Francesco Girolamo, Cristiana Coppola, Domenico Ribatti, et al.
Page
of 35
Search research articles
Search
Showing results (21-30 of 342) with videos related to
Sort By:
Page
of 35
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 3, 2009
Safety profile of Tysabri: international risk management plan
P Iaffaldano, M D'Onghia, Maria Trojano
Biologics : Targets & Therapy
|
August 27, 2009
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
Damiano Paolicelli, Vita Direnzo, Maria Trojano
Neurology
|
April 25, 2018
Complexity of MS management in the current treatment era
Tanuja Chitnis, Gavin Giovannoni, Maria Trojano
Expert Review of Neurotherapeutics
|
November 19, 2011
Treating multiple sclerosis with natalizumab
Pietro Iaffaldano, Guglielmo Lucchese, Maria Trojano
Journal of Neurology
|
June 5, 2016
Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients
Pietro Iaffaldano, Rosa Gemma Viterbo, Maria Trojano
Neurology
|
October 16, 2013
Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient
Carla Tortorella, Vita Direnzo, Mariangela D'Onghia, et al.
CNS Drugs
|
January 4, 2020
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis
Damiano Paolicelli, Alessia Manni, Antonio Iaffaldano, et al.
CNS Drug Reviews
|
July 14, 2007
Glatiramer acetate in multiple sclerosis: a review
Maddalena Ruggieri, Carlo Avolio, Paolo Livrea, et al.
Clinical and Experimental Medicine
|
December 26, 2014
First evidence of in vivo pro-angiogenic activity of cerebrospinal fluid samples from multiple sclerosis patients
Domenico Ribatti, Pietro Iaffaldano, Christian Marinaccio, et al.
Acta Neuropathologica Communications
|
July 23, 2014
Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
Francesco Girolamo, Cristiana Coppola, Domenico Ribatti, et al.
Page
of 35